Dr. Chartash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
126 East Scott Ave
Merck
Rahway, NJ 07065Phone+1 732-594-3505
Education & Training
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1982
Certifications & Licensure
NY State Medical License 1985 - 2020
NJ State Medical License 2005 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 218 citationsEfficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis...Michael H. Weisman, Larry W. Moreland, Daniel E. Furst, Michael E. Weinblatt, Edward C. Keystone
Clinical Therapeutics. 2003-06-01 - 1378 citationsAdalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: ...Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman
Arthritis and Rheumatism. 2003-01-01 - 129 citationsFirst-in-human phase 1 study of the anti–TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non–small cell lung cancerJiaxin Niu, Corinne Maurice-Dror, Dongwhane Lee, Dai Woo Kim, Adnan Nagrial
Annals of Oncology. 2021-11-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
